Title: Total Thyroidectomy for Graves’ disease – Our Experience
Authors: Dr S. Zahir Hussain, Dr M.P. Kumaran
DOI: https://dx.doi.org/10.18535/jmscr/v5i7.103
Abstract
Background: Graves’ disease represents an autoimmune disease of the thyroid gland Total Thyroidectomy has an important role in its treatment. The aim of our paper was to analyze the results of Total Thyroidectomy, the frequency of microcarcinoma, as well as to compare surgical complications
Methods: We analysed 300 patients (30 male and 270 female) who underwent surgery for Graves’ disease at the Department of Endocrine Surgery in Tertiary care Hospital during 10 years (2006–2016). Average age was 29 years. Frequency of surgical complications within the groups was analyzed.
Results: Total thyroidectomy (TT) was performed in 290 (90%) patients, and Dunhill operation (D) in 10 (3%). Carcinoma of thyroid gland was found in 30 patients (10%), all are microcarcinoma. Complication rates in the TT group, were 10 (3%) patients with permanent hypoparathyroidism, 3 (1%) patients with unilateral recurrent nerve paralysis. We don’t have any with postoperative bleeding and unilateral recurrent nerve paralysis
Conclusions: Frequency of complications were not significantly statistically different in relation to the type of surgical procedure. Total thyroidectomy represents a safe and efficient method for treating patients with Graves’ disease, and it is not followed by a greater frequency of complications in relation to less extensive procedures.
Keywords: Graves’ disease, Total thyroidectomy, Carcinoma, Complications.
References
1. Grodski S, Stalberg P, Robinson BG, Delbridge LW. Surgery versus radioiodine therapy as definitive management for Graves’ disease: the role of patient preference. Thyroid. 2007;17:157–60.
2. Palit TK, Miller 3rd CC, Miltenburg DM. The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res. 2000;90:161–5.
3. Werga-Kjellman P, Zedenius J, Tallstedt L, Träisk F, Lundell G, Wallin G. Surgical treatment of hyperthyroidism: a ten-year experience. Thyroid. 2001;11:187–92.
4. Witte J, Goretzki PE, Dotzenrath C, Simon D, Felis P, Neubauer M, et al. Surgery for Graves’ disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg. 2000;24:1303–11.
5. Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg. 2002;128:389–92.
6. Gittoes NJ, Franklyn JA. Hyperthyroidism: current treatment guidelines. Drugs. 1998;55:543.
7. Klementschitsch P, Shen K, Kaplan EL. Reemergence of thyroidectomy as treatment for Graves’ disease. Surg Clin North Am. 1979;59:35–44.
8. Boostrom S, Richards ML. Total thyroidectomy is the preferred treatment for patients with Graves’ disease and a thyroid nodule. Otolaryngol Head Neck Surg. 2007;136:278–81.
9. Alsanea O, Clark OH. Treatment of Graves’ disease: the advantages of surgery. Endocrinol Metab Clin North Am. 2000;29:321–37.
10. Wihelm SM, McHenry CR. Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves’disease in the United States. World J Surg. 2010;34:1261–4.
11. Kurihara H. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy. Thyroid. 2002;12:265–7.
12. Stalberg P, Svensson A, Hessman O, Akerstrom G, Hellman P. Surgical Treatment of Graves’ disease: evidence-based approach. World J Surg. 2008;32:1269–77.
13. Liu J, Bargren A, Schaefer S, Chen H, Sippel RS. Total thyroidectomy: a safe and effective treatment for Graves’ disease. J Surg Res. 2011;168:1–4.
14. Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH. Should total thyroidectomy become the preferred procedure for surgical management of Graves’ disease? Thyroid. 2005;15:569–74.
15. Feroci F, Rettori M, Borrelli A, Coppola A, Castagnoli A, Perigli G, et al. A systematic review and meta-analysis of total thyroidectomy versus bilateral subtotal thyroidectomy for Graves’ disease. Surgery. 2014;155:529–40.
16. Barakate MS, Agarwal G, Reeve TS, Barraclough B, Robinson B, Delbridge LW. Total thyroidectomy is now the preferred option for the surgical management of Graves’ disease. ANZ J Surg. 2002;7:321–4.
17. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves’ disease. J Clin Endocrinol Metab. 1990;70:1518–24.
18. Wiersinga WM, Prummel MF. Graves’ ophthalmopathy: a rational approach to treatment. Trends Endocrinol Metab. 2002;13:280–7.
19. Mishra A, Agarwal A, Agarwal G, Mishra SK. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg. 2001;25:307–10.
20. Friguglietti CU, Lin CS, Kulcsar MA. Total thyroidectomy for benign thyroid disease. Laryngoscope. 2003;113:1820–6.
21. Mittendorf EA, McHenry CR. Thyroidectomy for selected patients with thyrotoxicosis. Arch Otolaryngol Head Neck Surg. 2001;127:61–5.
22. Gabriele R, Letizia C, Borghese M, De Toma G, Celi M, Izzo L, et al. Thyroid cancer in patients with hyperthyroidism. Horm Res. 2003;60:79–83.
23. Calò PG, Tatti A, Farris S, Malloci A, Nicolosi A. Differentiated thyroid carcinoma and hyperthyroidism: a frequent association? Chir Ital. 2005;57:193–7.
24. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R. Outcome of differentiated thyroid cancer in Graves’ patients. J Clin Endocrinol Metab. 1998;83:2805–9.
25. Jenkins K, Baker AB. Consent and anesthetic risk. Anaesthesia. 2003;58:962–84.
26. Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H, et al. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 2003;133:180–5.